Immunome, Inc. (IMNM)
19.29
-0.02
(-0.10%)
USD |
NASDAQ |
Oct 07, 15:40
Immunome EPS Diluted (Quarterly) : -0.6456 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6456 |
| March 31, 2026 | -0.4759 |
| December 31, 2025 | -0.7516 |
| September 30, 2025 | -0.6532 |
| June 30, 2025 | -0.4988 |
| March 31, 2025 | -0.5244 |
| December 31, 2024 | -1.280 |
| September 30, 2024 | -0.7823 |
| June 30, 2024 | -0.6027 |
| March 31, 2024 | -2.512 |
| December 31, 2023 | -4.220 |
| September 30, 2023 | -0.3561 |
| June 30, 2023 | -0.4556 |
| March 31, 2023 | -0.3505 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.6932 |
| September 30, 2022 | -0.7036 |
| June 30, 2022 | -0.7359 |
| March 31, 2022 | -0.9612 |
| December 31, 2021 | -0.6484 |
| September 30, 2021 | -0.6469 |
| June 30, 2021 | -0.4574 |
| March 31, 2021 | -0.3663 |
| December 31, 2020 | -0.383 |
| September 30, 2020 | -0.7947 |
| June 30, 2020 | -0.2576 |
| March 31, 2020 | -2.435 |
| September 30, 2019 | -0.2596 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Erasca, Inc. | -0.1416 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.13M |
| Total Expenses (Quarterly) | 73.13M |
| Enterprise Value | 1.672B |
| Earnings Yield | -13.10% |
| Normalized Earnings Yield | -12.71 |